The Role of Liposomal Antioxidants in Oxidative Stress

  • Zacharias E. Suntres
  • Abdelwahab Omri


Reactive Oxygen Species Superoxide Dismutase Lung Injury Acute Lung Injury Intratracheal Instillation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sies, H. (1985). Oxidative stress: Introductory remarks. In: Oxidative Stress. (Sies, H., Ed), pp. 1-8. Academic Press Inc., New York.Google Scholar
  2. 2.
    Willcox, J. K., Ash, S. L. & Catignani, G. L. (2004). Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 44, 275-295.CrossRefPubMedGoogle Scholar
  3. 3.
    Djordjevic, V. B. (2004). Free radicals in cell biology. Int Rev Cytol 237, 57-89.CrossRefPubMedGoogle Scholar
  4. 4.
    Stohs, S. J. (1995). The role of free radicals in toxicity and disease. J Basic Clin Physiol Pharmacol 6, 205-228.PubMedGoogle Scholar
  5. 5.
    Pelicano, H., Carney, D. & Huang, P. (2004). ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7, 97-110.CrossRefPubMedGoogle Scholar
  6. 6.
    Kovacic, P. & Osuna, J. A., Jr. (2000). Mechanisms of anti-cancer agents: emphasis on oxidative stress and electron transfer. Curr Pharm Des 6, 277-309.CrossRefPubMedGoogle Scholar
  7. 7.
    Doroshow, J. H. (1986). Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc Natl Acad Sci USA 83, 4514-4518.CrossRefPubMedGoogle Scholar
  8. 8.
    Stohs, S. J. & Bagchi, D. (1995). Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med 18, 321-336.CrossRefPubMedGoogle Scholar
  9. 9.
    Suntres, Z. E. (2002). Role of antioxidants in paraquat toxicity. Toxicology 180, 65-77.CrossRefPubMedGoogle Scholar
  10. 10.
    Forman, H. J. & Torres, M. (2002). Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 166, S4-8.CrossRefPubMedGoogle Scholar
  11. 11.
    Di Virgilio, F. (2004). New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets. Curr Pharm Des 10, 1647-1652.CrossRefPubMedGoogle Scholar
  12. 12.
    Sies, H. (1987). Antioxidant activity in cells and organs. Am Rev Respir Dis 136, 478-480.PubMedGoogle Scholar
  13. 13.
    Toyokuni, S. (1999). Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 49, 91-102.CrossRefPubMedGoogle Scholar
  14. 14.
    Kadenbach, B., Arnold, S., Lee, I. et al. (2004). The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases. Biochim Biophys Acta 1655, 400-408.CrossRefPubMedGoogle Scholar
  15. 15.
    Zoratti, M. & Szabo, I. (1995). The mitochondrial permeability transition. Biochim Biophys Acta 1241, 139-176.PubMedGoogle Scholar
  16. 16.
    Bernardi, P. (1996). The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta 1275, 5-9.CrossRefPubMedGoogle Scholar
  17. 17.
    Bernardi, P. & Petronilli, V. (1996). The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J Bioenerg Biomembr 28, 131-138.CrossRefPubMedGoogle Scholar
  18. 18.
    Evans, P. & Halliwell, B. (2001). Micronutrients: oxidant/antioxidant status. Br J Nutr 85 Suppl 2, S67-74.Google Scholar
  19. 19.
    Gutteridge, J. M. & Halliwell, B. (2000). Free radicals and antioxidants in the year 2000. A historical look to the future. Ann N Y Acad Sci 899, 136-147.PubMedCrossRefGoogle Scholar
  20. 20.
    Suntres, Z. E., Omri, A. & Shek, P. N. (2002). Pseudomonas aeruginosa-induced lung injury: role of oxidative stress. Microb Pathog 32, 27-34.CrossRefPubMedGoogle Scholar
  21. 21.
    Chow, C. K. (2004). Biological functions and metabolic fate of vitamin E revisited. J Biomed Sci 11, 295-302.CrossRefPubMedGoogle Scholar
  22. 22.
    Halliwell, B. (1996). Vitamin C: antioxidant or pro-oxidant in vivo? Free Radic Res 25, 439-454.CrossRefPubMedGoogle Scholar
  23. 23.
    Carr, A. & Frei, B. (1999). Does vitamin C act as a pro-oxidant under physiological conditions? Faseb J 13, 1007-1024.PubMedGoogle Scholar
  24. 24.
    Anderson, M. E. (1997). Glutathione and glutathione delivery compounds. Adv Pharmacol 38, 65-78.CrossRefPubMedGoogle Scholar
  25. 25.
    Anderson, M. E. & Luo, J. L. (1998). Glutathione therapy: from prodrugs to genes. Semin Liver Dis 18, 415-424.CrossRefPubMedGoogle Scholar
  26. 26.
    Suntres, Z. E. & Shek, P. N. (1995). Liposome-associated antioxidants for pulmonary applications. In Liposomes in Biomedical Applications. (Shek, P., Ed), pp. 179-198. Harwood Academic Publishers, Singapore.Google Scholar
  27. 27.
    Stone, W. L. & Smith, M. (2004). Therapeutic uses of antioxidant liposomes. Mol Biotechnol 27, 217-230.CrossRefPubMedGoogle Scholar
  28. 28.
    Shek, P. N., Suntres, Z. E. & Brooks, J. I. (1994). Liposomes in pulmonary applications: physicochemical considerations, pulmonary distribution and antioxidant delivery. J Drug Target 2, 431-442.CrossRefPubMedGoogle Scholar
  29. 29.
    Allen, T. M. (1998). Liposomal drug formulations. Rationale for development and what we can expect for the future. Drugs 56, 747-756.CrossRefPubMedGoogle Scholar
  30. 30.
    Langner, M. & Kral, T. E. (1999). Liposome-based drug delivery systems. Pol J Pharmacol 51, 211-222.PubMedGoogle Scholar
  31. 31.
    Gilbert, B. E. (1996). Liposomal aerosols in the management of pulmonary infections. J Aerosol Med 9, 111-122.CrossRefPubMedGoogle Scholar
  32. 32.
    Taylor, M. G. & Farr, S. J. (1993). Liposomes for drug delivery to the respiratory tract. Drug Develop. Indust. Pharm. 19, 123-142.CrossRefGoogle Scholar
  33. 33.
    Kimelberg, H. K. & Mayhew, E. G. (1978). Properties and biological effects of liposomes and their uses in pharmacology and toxicology. CRC Crit. Rev. Toxicol. 96, 25-79.CrossRefGoogle Scholar
  34. 34.
    Yatvin, M. B. & Lelkes, P. I. (1982). Clinical prospects for liposomes. Med Phys 9, 149-175.CrossRefPubMedGoogle Scholar
  35. 35.
    Gregoriadis, G. (1991). Overview of liposomes. J Antimicrob Chemother 28 Suppl B, 39-48.PubMedGoogle Scholar
  36. 36.
    Gregoriadis, G. (1995). Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol 13, 527-537.CrossRefPubMedGoogle Scholar
  37. 37.
    Muzykantov, V. R. (2001). Targeting of superoxide dismutase and catalase to vascular endothelium. J Control Release 71, 1-21.CrossRefPubMedGoogle Scholar
  38. 38.
    Muzykantov, V. R. (2001). Delivery of antioxidant enzyme proteins to the lung. Antioxid Redox Signal 3, 39-62.CrossRefPubMedGoogle Scholar
  39. 39.
    Suntres, Z. E., Hepworth, S. R. & Shek, P. N. (1993). Pulmonary uptake of liposome-associated alpha-tocopherol following intratracheal instillation in rats. J Pharm Pharmacol 45, 514-520.PubMedGoogle Scholar
  40. 40.
    Corvo, M. L., Boerman, O. C., Oyen, W. J. et al. (1999). Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta 1419, 325-334.CrossRefPubMedGoogle Scholar
  41. 41.
    Walther, F. J., David-Cu, R. & Lopez, S. L. (1995). Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. Am J Physiol 269, L613-617.PubMedGoogle Scholar
  42. 42.
    Watanabe, H., Kobayashi, A., Yamamoto, T. et al. (1990). Alterations of human erythrocyte membrane fluidity by oxygen-derived free radicals and calcium. Free Radic Biol Med 8, 507-514.CrossRefPubMedGoogle Scholar
  43. 43.
    Cimato, A. N., Piehl, L. L., Facorro, G. B. et al. (2004). Antioxidant effects of water- and lipid-soluble nitroxide radicals in liposomes. Free Radic Biol Med 37, 2042-2051.CrossRefPubMedGoogle Scholar
  44. 44.
    Sengupta, B., Banerjee, A. & Sengupta, P. K. (2004). Investigations on the binding and antioxidant properties of the plant flavonoid fisetin in model biomembranes. FEBS Lett 570, 77-81.CrossRefPubMedGoogle Scholar
  45. 45.
    Zhang, Y., Cichewicz, R. H. & Nair, M. G. (2004). Lipid peroxidation inhibitory compounds from daylily (Hemerocallis fulva) leaves. Life Sci 75, 753-763.CrossRefPubMedGoogle Scholar
  46. 46.
    Zago, M. P. & Oteiza, P. I. (2001). The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic Biol Med 31, 266-274.CrossRefPubMedGoogle Scholar
  47. 47.
    Junghans, A., Sies, H. & Stahl, W. (2001). Carotenoid-Containing Unilamellar Liposomes Loaded with Glutathione: a Model to Study Hydrophobic-Hydrophilic Antioxidant Interaction. Free Radic Res 33, 801-808.CrossRefGoogle Scholar
  48. 48.
    Leedle, R. A. & Aust, S. D. (1990). The effect of glutathione on the vitamin E requirement for inhibition of liver microsomal lipid peroxidation. Lipids 25, 241-245.CrossRefPubMedGoogle Scholar
  49. 49.
    Yeagle, P. L. (1993). Phosphorus-31 nuclear magnetic resonance in membrane fusion studies. Methods Enzymol 220, 68-79.CrossRefPubMedGoogle Scholar
  50. 50.
    Yegin, A., Akbas, S. H., Ozben, T. et al. (2002). Secretory phospholipase A2 and phospholipids in neural membranes in an experimental epilepsy model. Acta Neurol Scand 106, 258-262.CrossRefPubMedGoogle Scholar
  51. 51.
    de Lima, V. R., Morfim, M. P., Teixeira, A. et al. (2004). Relationship between the action of reactive oxygen and nitrogen species on bilayer membranes and antioxidants. Chem Phys Lipids 132, 197-208.CrossRefPubMedGoogle Scholar
  52. 52.
    Crestanello, J. A., Kamelgard, J., Lingle, D. M. et al. (1996). Elucidation of a tripartite mechanism underlying the improvement in cardiac tolerance to ischemia by coenzyme Q10 pretreatment. J Thorac Cardiovasc Surg 111, 443-450.CrossRefPubMedGoogle Scholar
  53. 53.
    Fan, J., Shek, P. N., Suntres, Z. E. et al. (2000). Liposomal antioxidants provide prolonged protection against acute respiratory distress syndrome. Surgery 128, 332-338.CrossRefPubMedGoogle Scholar
  54. 54.
    Mandal, A. K., Sinha, J., Mandal, S. et al. (2002). Targeting of liposomal flavonoid to liver in combating hepatocellular oxidative damage. Drug Deliv 9, 181-185.CrossRefPubMedGoogle Scholar
  55. 55.
    Freeman, B. A., Turrens, J. F., Mirza, Z. et al. (1985). Modulation of oxidant lung injury by using liposome-entrapped superoxide dismutase and catalase. Fed Proc 44, 2591-2595.PubMedGoogle Scholar
  56. 56.
    Beckman, J. S., Minor, R. L., Jr. & Freeman, B. A. (1986). Augmentation of antioxidant enzymes in vascular endothelium. J Free Radic Biol Med 2, 359-365.CrossRefPubMedGoogle Scholar
  57. 57.
    Turrens, J. F., Crapo, J. D. & Freeman, B. A. (1984). Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 73, 87-95.CrossRefPubMedGoogle Scholar
  58. 58.
    Cruz, M. E., Manuela Gaspar, M., Barbara, M. et al. (2005). Liposomal superoxide dismutases and their use in the treatment of experimental arthritis. Methods Enzymol 391, 395-413.CrossRefPubMedGoogle Scholar
  59. 59.
    Nakae, D., Yamamoto, K., Yoshiji, H. et al. (1990). Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. Am J Pathol 136, 787-795.PubMedGoogle Scholar
  60. 60.
    Homi, H. M., Freitas, J. J., Curi, R. et al. (2002). Changes in superoxide dismutase and catalase activities of rat brain regions during early global transient ischemia/reperfusion. Neurosci Lett 333, 37-40.CrossRefPubMedGoogle Scholar
  61. 61.
    Chan, P. H. (1992). Antioxidant-dependent amelioration of brain injury: role of CuZn-superoxide dismutase. J Neurotrauma 9 Suppl 2, S417-423.Google Scholar
  62. 62.
    Stanimirovic, D. B., Markovic, M., Micic, D. V. et al. (1994). Liposome-entrapped superoxide dismutase reduces ischemia/reperfusion ‘oxidative stress’ in gerbil brain. Neurochem Res 19, 1473-1478.CrossRefPubMedGoogle Scholar
  63. 63.
    Baillet, F., Housset, M., Michelson, A. M. et al. (1986). Treatment of radiofibrosis with liposomal superoxide dismutase. Preliminary results of 50 cases. Free Radic Res Commun 1, 387-394.CrossRefPubMedGoogle Scholar
  64. 64.
    Delanian, S., Baillet, F., Huart, J. et al. (1994). Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol 32, 12-20.CrossRefPubMedGoogle Scholar
  65. 65.
    Petelin, M., Pavlica, Z., Ivanusa, T. et al. (2000). Local delivery of liposome- encapsulated superoxide dismutase and catalase suppress periodontal inflammation in beagles. J Clin Periodontol 27, 918-925.CrossRefPubMedGoogle Scholar
  66. 66.
    Tanswell, A. K. & Freeman, B. A. (1987). Liposome-entrapped antioxidant enzymes prevent lethal O2 toxicity in the newborn rat. J Appl Physiol 63, 347-352.PubMedGoogle Scholar
  67. 67.
    Ledwozyw, A. (1991). Protective effect of liposome-entrapped superoxide dismutase and catalase on bleomycin-induced lung injury in rats. I. Antioxidant enzyme activities and lipid peroxidation. Acta Vet Hung 39, 215-224.PubMedGoogle Scholar
  68. 68.
    Suntres, Z. E. & Shek, P. N. (1995). Liposomal alpha-tocopherol alleviates the progression of paraquat-induced lung damage. J Drug Target 2, 493-500.CrossRefPubMedGoogle Scholar
  69. 69.
    Suntres, Z. E. & Shek, P. N. (1994). Incorporation of alpha-tocopherol in liposomes promotes the retention of liposome-encapsulated glutathione in the rat lung. J Pharm Pharmacol 46, 23-28.PubMedGoogle Scholar
  70. 70.
    Smith, L. J., Anderson, J. & Shamsuddin, M. (1992). Glutathione localization and distribution after intratracheal instillation. Implications for treatment. Am Rev Respir Dis 145, 153-159.PubMedGoogle Scholar
  71. 71.
    Cooke, R. W. & Drury, J. A. (2005). Reduction of oxidative stress marker in lung fluid of preterm infants after administration of intra-tracheal liposomal glutathione. Biol Neonate 87, 178-180.CrossRefPubMedGoogle Scholar
  72. 72.
    Suntres, Z. E., Hepworth, S. R. & Shek, P. N. (1992). Protective effect of liposome-associated alpha-tocopherol against paraquat-induced acute lung toxicity. Biochem Pharmacol 44, 1811-1818.CrossRefPubMedGoogle Scholar
  73. 73.
    Suntres, Z. E. & Shek, P. N. (1995). Intratracheally administered liposomal alpha-tocopherol protects the lung against long-term toxic effects of paraquat. Biomed Environ Sci 8, 289-300.PubMedGoogle Scholar
  74. 74.
    Suntres, Z. E. & Shek, P. N. (1995). Prevention of phorbol myristate acetate-induced acute lung injury by alpha-tocopherol liposomes. J Drug Target 3, 201-208.CrossRefPubMedGoogle Scholar
  75. 75.
    Suntres, Z. E. & Shek, P. N. (1996). Treatment of LPS-induced tissue injury: role of liposomal antioxidants. Shock 6 Suppl 1, S57-64.Google Scholar
  76. 76.
    Suntres, Z. E. & Shek, P. N. (1996). Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing alpha-tocopherol and glutathione. Biochem Pharmacol 52, 1515-1520.CrossRefPubMedGoogle Scholar
  77. 77.
    Suntres, Z. E. & Shek, P. N. (1996). The pulmonary uptake of intravenously administered liposomal alpha-tocopherol is augmented in acute lung injury. J Drug Target 4, 151-159.CrossRefPubMedGoogle Scholar
  78. 78.
    Suntres, Z. E. & Shek, P. N. (1997). Protective effect of liposomal alpha-tocopherol against bleomycin-induced lung injury. Biomed Environ Sci 10, 47-59.PubMedGoogle Scholar
  79. 79.
    Suntres, Z. E. & Shek, P. N. (1998). Prophylaxis against lipopolysaccharide-induced acute lung injury by alpha-tocopherol liposomes. Crit Care Med 26, 723-729.CrossRefPubMedGoogle Scholar
  80. 80.
    Suntres, Z. E. & Shek, P. N. (1998). Liposomes promote pulmonary glucocorticoid delivery. J Drug Target 6, 175-182.CrossRefPubMedGoogle Scholar
  81. 81.
    Ramazzotto, L. J. & Engstrom, R. (1975). Dietary vitamin E and the effects of inhaled nitrogen dioxide on rat lungs. Environ Physiol Biochem 5, 226-234.PubMedGoogle Scholar
  82. 82.
    Redetzki, H. M., Wood, C. D. & Grafton, W. D. (1980). Vitamin E and paraquat poisoning. Vet Hum Toxicol 22, 395-397.PubMedGoogle Scholar
  83. 83.
    Stephens, R. J., Buntman, D. J., Negi, D. S. et al. (1983). Tissue levels of vitamin E in the lung and the cellular response to injury resulting from oxidant gas exposure. Chest 83, 37S-39S.PubMedGoogle Scholar
  84. 84.
    Warren, D. L., Hyde, D. M. & Last, J. A. (1988). Synergistic interaction of ozone and respirable aerosols on rat lungs. IV. Protection by quenchers of reactive oxygen species. Toxicology 53, 113-133.CrossRefPubMedGoogle Scholar
  85. 85.
    Yasaka, T., Okudaira, K., Fujito, H. et al. (1986). Further studies of lipid peroxidation in human paraquat poisoning. Arch Intern Med 146, 681-685.CrossRefPubMedGoogle Scholar
  86. 86.
    Gallo-Torres, H. E. (1980). Transport and metabolism. Marcel Dekker, New York.Google Scholar
  87. 87.
    Knight, M. E. & Roberts, R. J. (1985). Tissue vitamin E levels in newborn rabbits after pharmacologic dosing: influence of dose, dosage form and route of administration. Dev. Pharmacol. Ther. 8, 96-106.PubMedGoogle Scholar
  88. 88.
    Crane, F. L. (2001). Biochemical functions of coenzyme Q10. J Am Coll Nutr 20, 591-598.PubMedGoogle Scholar
  89. 89.
    Niibori, K., Yokoyama, H., Crestanello, J. A. et al. (1998). Acute administration of liposomal coenzyme Q10 increases myocardial tissue levels and improves tolerance to ischemia reperfusion injury. J Surg Res 79, 141-145.CrossRefPubMedGoogle Scholar
  90. 90.
    Soloviev, A., Stefanov, A., Parshikov, A. et al. (2002). Arrhythmogenic peroxynitrite-induced alterations in mammalian heart contractility and its prevention with quercetin-filled liposomes. Cardiovasc Toxicol 2, 129-139.CrossRefPubMedGoogle Scholar
  91. 91.
    Sinha, J., Das, N. & Basu, M. K. (2001). Liposomal antioxidants in combating ischemia- reperfusion injury in rat brain. Biomed Pharmacother 55, 264-271.CrossRefPubMedGoogle Scholar

Copyright information

© Springer 2006

Authors and Affiliations

  • Zacharias E. Suntres
    • 1
  • Abdelwahab Omri
    • 2
  1. 1.Medical Sciences Division Northern Ontario School of MedicineLakehead UniversityThunder BayCanada
  2. 2.The Novel Drug and Vaccine Delivery Systems Facility, Department of ChemistLaurentian UniversitySudburyCanada

Personalised recommendations